Filana Therapeutics, Inc. (FLNA)
0.6475
0.00 (0.00%)
USD |
NASDAQ |
Oct 28, 12:12
Filana Therapeutics Cash from Operations (Quarterly) : -3.855M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.855M |
| March 31, 2026 | -8.878M |
| December 31, 2025 | -9.748M |
| September 30, 2025 | -6.221M |
| June 30, 2025 | -4.947M |
| March 31, 2025 | -11.34M |
| December 31, 2024 | -61.26M |
| September 30, 2024 | -18.30M |
| June 30, 2024 | -18.24M |
| March 31, 2024 | -19.13M |
| December 31, 2023 | -22.32M |
| September 30, 2023 | -26.53M |
| June 30, 2023 | -19.92M |
| March 31, 2023 | -13.26M |
| December 31, 2022 | -21.32M |
| September 30, 2022 | -21.55M |
| June 30, 2022 | -11.11M |
| March 31, 2022 | -23.53M |
| December 31, 2021 | -7.987M |
| September 30, 2021 | -14.76M |
| June 30, 2021 | -5.139M |
| March 31, 2021 | -2.306M |
| December 31, 2020 | -1.175M |
| September 30, 2020 | -2.171M |
| June 30, 2020 | -0.842M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.194M |
| December 31, 2019 | -0.589M |
| September 30, 2019 | -0.73M |
| June 30, 2019 | -0.591M |
| March 31, 2019 | -0.604M |
| December 31, 2018 | -0.565M |
| September 30, 2018 | -1.436M |
| June 30, 2018 | -1.126M |
| March 31, 2018 | -1.643M |
| December 31, 2017 | -1.437M |
| September 30, 2017 | -2.151M |
| June 30, 2017 | -3.197M |
| March 31, 2017 | -1.452M |
| December 31, 2016 | -3.031M |
| September 30, 2016 | -2.787M |
| June 30, 2016 | -3.274M |
| March 31, 2016 | -3.142M |
| December 31, 2015 | -3.548M |
| September 30, 2015 | -2.41M |
| June 30, 2015 | -1.948M |
| March 31, 2015 | -1.147M |
| December 31, 2014 | -2.563M |
| September 30, 2014 | -1.672M |
| June 30, 2014 | -2.591M |
| March 31, 2014 | -2.723M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| CorMedix, Inc. | 86.06M |
| Eloxx Pharmaceuticals, Inc. | -4.789M |
| Breakthrough Chemistry, Inc. | -0.0073M |
| BioStem Technologies, Inc. | -5.538M |
| Cardiac Biotech Solutions, Inc. | -0.1918M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | -0.016M |
| Free Cash Flow | -29.30M |
| Free Cash Flow Per Share (Quarterly) | -0.0802 |
| Free Cash Flow to Equity (Quarterly) | -3.876M |
| Free Cash Flow to Firm (Quarterly) | -3.876M |
| Free Cash Flow Yield | -93.68% |